Medtech companies need to take heed as Chinese corruption clampdown spreads
This article was originally published in SRA
Executive Summary
Medtech companies doing business in China would do well to conduct a special internal audit as Chinese authorities intensify their scrutiny on inappropriate conduct within the healthcare industry.